Research

PREVAIL STUDY

Our practice is taking part in a research study called PREVAIL. The study will assess a quality improvement programme called CONQUEST. This is a new way to find, and improve care and treatment for patients with a lung condition known as COPD or may be at risk of having this condition, who experience flare-ups of their symptoms.

As part of this research, de-identified data about our patients will be shared with the PREVAIL research team. This is data that does not have any information that would identify our patients. No personal details will be shared with the research team.

If you do not want your data to be shared for research purposes, you can withdraw from sharing your data at any time. This will not affect the care that you receive from us.

If you have any questions about this study or how your de-identified information is used, or you wish to withdraw from sharing your data for research purposes, visit www.digital.nhs.uk/services/national-data-opt-out
For more information please go to:
Website: www. opri.org.uk/prevail
Phone: 01223 967 855
Email: prevail@opri.org.uk

Evaluation of aid to diagnosis for congenital dysplasia of the hip in general practice:

Sponsered by Great Ormond Stret Hospital the objectives for this trial are:

  1. To determine whether the use of a check list for the 6-week hip check can (i) reduce the number of clinically insignificant referrals from primary to secondary care, and (ii) reduce the number of DDH diagnosed beyond the age of 12 weeks.
  2. To determine the cost-effectiveness of this intervention considering a life time horizon.
  3. To conduct an integrated qualitative and quantitative process evaluation in order to: understand the participants' experience with the intervention; identify how the intervention affects GPs’ capability, opportunity and motivation in relation to the 6-week check; study how the intervention is implemented; and investigate how contextual factors affect uptake of the intervention

When booking your childs 6 week check you will be given inforamtion about this trial and asked if you wish to participate.  

Page last reviewed: 28 January 2022
Page created: 28 January 2022